Upfront investment burden associated with expanding R&D capabilities
First written in FY2020-Q1. 3 of 6 entries say "Materialised", first in FY2020-Q3. Latest entry: FY2026.
Takano moved to the "Worse" side of this theme in 2020.
0 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥562 million.」
R&D expenses decreased from ¥642.973 million in the previous fiscal year to ¥562.814 million, reducing the expense burden associated with upfront investment to expand the R&D structure. - FY2021MaterialisedAnnual report
「Although the Company worked to reduce costs aggressively, operating loss was ¥97 million, compared with operating profit of ¥754 million in the previous consolidated fiscal year, due to the impact of lower sales and upfront investment to expand the R&D structure, among other factors.」
Upfront investment to expand the R&D structure emerged as a factor behind the full-year operating loss alongside lower sales. R&D expenses were ¥896 million, up from ¥854 million in the previous fiscal year. - FY2021-Q3WorsenedAnnual report
「Although the Company worked to reduce costs aggressively, operating loss was ¥829 million, compared with operating profit of ¥210 million in the same period of the previous year, due to the impact of lower sales and upfront investment to expand the R&D structure, among other factors.」
Upfront investment to expand the R&D structure continued to contribute to operating loss alongside lower sales. Cumulative R&D expenses were ¥640 million, exceeding ¥591 million in the same period of the previous year. - FY2020MaterialisedAnnual report
「Selling, general and administrative expenses increased 8.9%, or ¥372 million, from the previous consolidated fiscal year to ¥4,564 million, due to higher salaries and allowances resulting from an increase in employees following the business acquisition conducted in the previous consolidated fiscal year, as well as increased upfront investment in new R&D fields.」
The increase in employees following the business acquisition and upfront investment in new R&D fields increased SG&A expenses by ¥372 million, and the burden weighing on profit continued. - FY2020-Q3MaterialisedAnnual report
「Although the Company actively pursued cost-reduction initiatives, including design standardization, segment profit was ¥169 million, down 33.9%, due mainly to the impact of upfront investment in R&D.」
Upfront investment in R&D continued to weigh on profit in the inspection and measurement equipment business. R&D expenses were ¥591 million. - FY2020-Q1First statedAnnual report
「Although the Company worked to reduce costs aggressively, operating profit was ¥172 million, down ¥79 million, or 31.4%, year on year, due to the impact of lower sales and upfront investment to expand the R&D structure.」
Upfront investment to expand the R&D structure was identified for the first time as a factor weighing on operating profit alongside lower sales.